Halozyme Therapeutics, Inc. (HALO): Are Hedge Funds Right About This Stock? – Merrimack Pharmaceuticals Inc (MACK), TESARO Inc (TSRO)

Halozyme Therapeutics, Inc. (NASDAQ:HALO) has seen an increase in hedge fund interest in recent months.

Halozyme Therapeutics, Inc. (NASDAQ:HALO)

To most stock holders, hedge funds are perceived as worthless, old financial vehicles of years past. While there are more than 8000 funds in operation at the moment, we hone in on the upper echelon of this club, close to 450 funds. It is estimated that this group has its hands on most of the hedge fund industry’s total capital, and by watching their best equity investments, we have spotted a few investment strategies that have historically outpaced the broader indices. Our small-cap hedge fund strategy outpaced the S&P 500 index by 18 percentage points annually for a decade in our back tests, and since we’ve began to sharing our picks with our subscribers at the end of August 2012, we have outperformed the S&P 500 index by 24 percentage points in 7 months (see all of our picks from August).

Equally as beneficial, bullish insider trading activity is another way to parse down the stock market universe. There are lots of reasons for an upper level exec to cut shares of his or her company, but only one, very simple reason why they would behave bullishly. Various academic studies have demonstrated the valuable potential of this method if investors know where to look (learn more here).

Consequently, let’s take a gander at the latest action encompassing Halozyme Therapeutics, Inc. (NASDAQ:HALO).

How are hedge funds trading Halozyme Therapeutics, Inc. (NASDAQ:HALO)?

In preparation for this year, a total of 12 of the hedge funds we track were bullish in this stock, a change of 9% from one quarter earlier. With the smart money’s capital changing hands, there exists an “upper tier” of key hedge fund managers who were increasing their stakes meaningfully.

According to our comprehensive database, QVT Financial, managed by Daniel Gold, holds the largest position in Halozyme Therapeutics, Inc. (NASDAQ:HALO). QVT Financial has a $25.4 million position in the stock, comprising 1.7% of its 13F portfolio. Sitting at the No. 2 spot is Baker Bros. Advisors, managed by Julian Baker and Felix Baker, which held a $11.9 million position; 0.3% of its 13F portfolio is allocated to the stock. Other hedgies with similar optimism include Israel Englander’s Millennium Management, Jerome Pfund and Michael Sjostrom’s Sectoral Asset Management and John A. Levin’s Levin Capital Strategies.

As industrywide interest jumped, key money managers have been driving this bullishness. Sectoral Asset Management, managed by JΘr⌠me Pfund and Michael Sj÷str÷m, assembled the biggest position in Halozyme Therapeutics, Inc. (NASDAQ:HALO). Sectoral Asset Management had 5.8 million invested in the company at the end of the quarter. Jim Simons’s Renaissance Technologies also made a $1.1 million investment in the stock during the quarter. The following funds were also among the new HALO investors: Mike Vranos’s Ellington, D. E. Shaw’s D E Shaw, and Steven Cohen’s SAC Capital Advisors.

What have insiders been doing with Halozyme Therapeutics, Inc. (NASDAQ:HALO)?

Insider buying is particularly usable when the primary stock in question has seen transactions within the past 180 days. Over the last six-month time frame, Halozyme Therapeutics, Inc. (NASDAQ:HALO) has experienced 2 unique insiders buying, and zero insider sales (see the details of insider trades here).

Let’s go over hedge fund and insider activity in other stocks similar to Halozyme Therapeutics, Inc. (NASDAQ:HALO). These stocks are InterMune Inc (NASDAQ:ITMN), Merrimack Pharmaceuticals Inc (NASDAQ:MACK), TESARO Inc (NASDAQ:TSRO), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), and EXACT Sciences Corporation (NASDAQ:EXAS). This group of stocks are the members of the biotechnology industry and their market caps match HALO’s market cap.

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
InterMune Inc (NASDAQ:ITMN) 14 0 0
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) 7 3 1
TESARO Inc (NASDAQ:TSRO) 2 1 0
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) 12 0 4
EXACT Sciences Corporation (NASDAQ:EXAS) 11 2 0

With the returns shown by the aforementioned strategies, everyday investors should always pay attention to hedge fund and insider trading activity, and Halozyme Therapeutics, Inc. (NASDAQ:HALO) shareholders fit into this picture quite nicely.

Click here to learn why you should track hedge funds

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 44 percentage points in 21 months Learn how!

Lists

The Top 10 States With Fastest Internet Speeds

10 Best Places to Visit in USA in August

Top 10 Cities to Visit Before You Die

Top 10 Genetically Modified Food In the US

15 Highest Grossing Movies Opening Weekend

5 Best Poker Books For Beginners

10 Strategies Hedge Funds Use to Make Huge Returns

Top 10 Fast Food Franchises to Buy

10 Best Places to Visit in Canada

Best Summer Jobs for Teachers

10 Youngest Hedge Fund Billionaires

Top 10 One Hit Wonders of the 90s

Fastest Growing Cities In America

Top 10 U.S. Cities for Freelancers

Top 9 Most Popular Free iPhone Apps

Top 10 Least Expensive Private Business Schools in the US

Top 15 Most Expensive Countries in the World – 2014

Top Businesses to Invest In

Top 5 Things You Might Be Doing Wrong With Your Business

Top 5 Strategic Technology Trends in 2014

Top Rags to Riches Stories

Parenting Behavior That Promotes Future Leaders

Top 5 Mistakes Made by Small Businesses

Top 5 Most Common and Potentially Devastating Financial Blunders

Top 5 Highest Paying Jobs for Web Designers

Top 6 Most Respected Professions that Also Pay Well

Top 5 Pitfalls Investors Should Avoid

Top 6 Lawyers and Policy Makers Under 30

Top 6 New Year’s Resolutions for Entrepreneurs

Top 7 Locations to Check in on Facebook

Top 5 Mistakes made by Rookie eBay Sellers

Top 7 eBook Publishers in 2013

Top 6 Health Industry Trends in 2014

5 Lessons for Entrepreneurs from Seth Godin

Top 5 Success Tips from Jordan Belfort – the Wolf of Wall Street

Best Master’s in Finance Degree Programs

Top 6 Earning Celebrities Over 50

The most expensive sports to play

Top 7 Earning Celebrities Under 25

Best 7 Online Courses to Take: Free Finance MOOCs

Top 6 Bad Habits that Promote Failure

20 Most Valuable Soccer Teams in the World in 2013

12 Most Expensive Countries for Foreign Students

Top 30 Most Influential Women in the World

Top 20 Most Expensive New Year Eve Shows

Top 5 Best Vocational Careers

Top 10 Jobs for 2014 by Salary Gain (Predictions)

Top 5 Digital Trends for 2014

Top 6 Things You Can Do To Increase Your Productivity

Top 9 Trending Smartphones in 2013

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!